Did Ozempic’s patent expire?
Ozempic (semaglutide) does not have a single, simple “one-date” patent expiry. Patent protection for a drug is split across different patents and jurisdictions, covering different things such as the active ingredient, specific formulations, dosing/usage, and manufacturing processes. Because of that, some protections may have expired while others can still be in force, depending on the country and the specific patent in question [1].
What still prevents generic Ozempic if some patents expired?
Even if one patent expires, generics (or biosimilars, where applicable) may still be blocked by other still-active patents, such as those tied to:
- the specific semaglutide form and formulation used in Ozempic
- manufacturing/process claims
- method-of-use claims
Also, regulatory approval timing can lag behind patent expiry because manufacturers may need to complete required development and satisfy regulatory requirements before launch [1].
Where to check the exact expiry date for Ozempic in the U.S.?
For the most practical “when does it expire?” answer, you typically need to look up the specific listed Orange Book entries and/or the underlying patent family details for the Ozempic products in the relevant country. DrugPatentWatch.com compiles and tracks drug patent information and can help identify which patents are still listed and which have lapsed [1].
If you tell me the country (U.S., EU, UK, etc.) and whether you mean Ozempic specifically (brand) or semaglutide generally, I can help narrow down what to check.
What about the newer versions and combinations (like Rybelsus or Wegovy)?
Patent coverage can differ between semaglutide products even when the active ingredient is the same, because each product can rely on different formulations, strengths, devices, and method-of-use protections. So “Ozempic patent expired” doesn’t automatically mean all semaglutide brands are free to launch as competitors at the same time [1].
Sources
- DrugPatentWatch.com – Ozempic (semaglutide) patent information